Stock itci
Earnings for Intra-Cellular Therapies are expected to grow in the coming year, from ($1.68) to ($0.80) per share. Intra-Cellular Therapies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.Notably, institutional investors and hedge funds currently own approximately 85.70% of ITCI stock. This demonstrates their trust in Intra-Cellular Therapies’ ability to revolutionize treatment options for neuropsychiatric and neurological disorders. On Friday, ITCI shares opened at $62.27. The firm has maintained a 50-day moving average price ...
Did you know?
February 22, 2023 at 10:00 AM · 5 min read. The market expects Intra-Cellular Therapies (ITCI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...The firm decreased its portfolio allocation in ITCI by 99.89% over the last quarter. ITOT - iShares Core S&P Total U.S. Stock Market ETF holds 89K shares representing 0.09% ownership of the company.Intra-Cellular Therapies Inc. Common Stock (ITCI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest Intra-Cellular Therapies, Inc. (ITCI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.$-1.63 Market Cap $5.46 B Shares Outstanding 96.24 M Public Float 93.82 M Yield ITCI is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23)...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.ETFs with Intra-Cellular Therapies, Inc. (ITCI). 68. ETFs Hold ITCI. 8.2M. ITCI Shares in ETFs. IWM. Biggest Holder. PSIL. Largest Allocation ...Apr 26, 2017 · ITCI - place your bets With a huge upcoming catalyst - CAPLYTA PDUFA due December 17th, 2021, it will make or break this stock - with an approval from the FDA, I expect pt of around 57, with possibility to hit all-time high within a year from CAPLYTA launch. 8 analysts have issued 12-month price targets for Intra-Cellular Therapies' stock. Their ITCI share price targets range from $62.00 to $101.00. On average, they …NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Join Our Free Stock Market Newsletter: StockMarket.com is the #1 resource for all things Stocks. Sign up today for Free!Dec 14, 2021 · Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shareholders might be concerned after seeing the share price drop 11% in the last month.But that doesn't change the fact that the returns over the last ... ITCI market cap is currently $4.31B and has a P/E ratio of -12.36. Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock.Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online. The net and percent change in the quote ...ETFs with Intra-Cellular Therapies, Inc. (ITCI). 68. ETFs Hold ITCI. 8.2M. ITCI Shares in ETFs. IWM. Biggest Holder. PSIL. Largest Allocation ...18 thg 10, 2023 ... The ITCI gives a comprehensive overview of how developed countries' tax ... shares of stock.[74] These types of taxes increase the cost of ...Nov 17, 2023 · Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.On November 2, 2023, Intra-Cellular Therapies Inc (ITCI) stock had 50.24%. Get the latest Intra-Cellular Thera Complete Intra-Cellular Therapies Inc. stock information by Barron's. View real-time ITCI stock price and news, along with industry-best analysis.Nov 30, 2023 · 8 Wall Street analysts have issued 1-year target prices for Intra-Cellular Therapies' stock. Their ITCI share price targets range from $62.00 to $101.00. On average, they predict the company's stock price to reach $78.67 in the next year. This suggests a possible upside of 28.2% from the stock's current price. The company was founded by Paul Greengard and Sharon Mate NEW YORK Dec. 06 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development. NEW YORK Dec. 06 2021 (GLOBE NEWSWIRE) -- Intra ... home / stock / itci / itci news. RSS . ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board. December, 06 2021 … Briefing From The Editor -- ITCI Stock. Now tra
ITCI stock shot up to approximately $55 per share after the success of study 403. There is some overhead supply to work through to reach new all-time highs and continued strong sales momentum and ...As of April 23, 2023, the average one-year price target for Intra-Cellular Therapies is 77.93. The forecasts range from a low of 56.56 to a high of $102.90. The average price target represents an ...Intra-Cellular Therapies (ITCI), another stock in the Zacks Medical - Biomedical and Genetics industry, is expected to report earnings per share of $0.63 for the quarter ended March 2023.Intra-Cellular Therapies Inc. Common Stock (ITCI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Even on an earnings season day when a clutch of companies notched earnings beats, Intra-Cellular Therapies' (ITCI 2.46%) first-quarter beat was notably impressive. Investors liked what they saw in ...Oct 9, 2023 · Intra-Cellular Therapies (ITCI) Jefferies analyst Andrew Tsai maintained a Buy rating on Intra-Cellular Therapies on October 6 and set a price target of $95.00 . The company’s shares closed last ... …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. May 4, 2023 · Intra-Cellular: Q1 Earnings Snapshot. . Possible cause: Stock Ideas and Recommendations. Get daily stock ideas from top-perform.
Nov 7, 2023 · Shares of Intra-Cellular Therapies (ITCI) have gained 7.7% over the past four weeks to close the last trading session at $56.01, but there could still be a solid upside left in the stock if short ...
Nov 7, 2023 · by Zacks Equity Research Published on November 07,2023. The mean of analysts' price targets for Intra-Cellular (ITCI) points to a 41.2% upside in the stock. While this highly sought-after metric ... Find the latest dividend history for Intra-Cellular Therapies Inc. Common Stock (ITCI) at Nasdaq.com.
March 31, 2023 at 11:30 AM · 4 min read. It has been ab Dec 1, 2023 · The average price recommended by analysts for Intra-Cellular Therapies Inc (ITCI) is $77.54, which is $16.26 above the current market price. The public float for ITCI is 93.65M and currently, short sellers hold a 3.65% of that float. On December 01, 2023, ITCI’s average trading volume was 845.52K shares. Top 5 EV Tech Stocks to Buy for 2023. Market Cap. MediciNova Inc. -2.63%. $90.74M. ITCI | CompletIntraCellular Therapies - ITCI - Stock Price Today - Zacks IntraCell Have the markets turned the corner? Maybe not – but maybe so, at least for the short term. Despite rising inflation in the States, and Russia’s continuing war against Ukraine, high prices for ...Intra-Cellular Therapeutics ITCI incurred a loss of 45 cents per share in fourth-quarter 2022, narrower than the Zacks Consensus Estimate of a loss of 62 cents. The reported loss per share is also ... NasdaqGS:ITCI Insider Trading Volume December 3rd 2023. For those Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Nov 19, 2023 · The average 1-year target price amonNov 20, 2023 · Shares of ITCI responded in kinThe firm decreased its portfolio allocation i Latest Intra-Cellular Therapies News: View ITCI news and discuss market sentiment with the investor community on Public.com.Nov 28, 2023 · Nov. 08. CI. RBC Trims Price Target on Intra-Cellular Therapies to $76 From $77, Keeps Outperform Rating. Nov. 03. MT. Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q3 Revenue $126.2M. Nov. 02. MT. Transcript : Intra-Cellular Therapies, Inc., Q3 2023 Earnings Call, Nov 02, 2023. Find the latest Institutional Holdings data for Intra-Cell Intra-Cellular Therapies (ITCI) closed the last trading session at $51.22, gaining 6.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ... NEW YORK Dec. 06 2021 (GLOBE NEWSWIRE) -[Current Price $59.26 Daily Change (1.2%) $0.73 Day's Range $58.34Ticker Symbol: ITCI: Exchange: NASDAQ: Fiscal Year: January - December Shares of Intra-Cellular Therapies (ITCI) have gained 18.4% over the past four weeks to close the last trading session at $52.87, but there could still be a solid upside left in the stock if short ...